US Patent 11976135 FIXaxFX bispecific antibody with common light chain
Patent 11976135 was granted and assigned to Kymab on May, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 8 May, 2024
Golden AI
Edits made to:
Infobox (+16 properties)
Article (+354 characters)
US Patent 11976135 FIXaxFX bispecific antibody with common light chain
Article
Patent abstract
Bispecific antigen binding molecules (e.g., antibodies) that bind blood clotting factors, factor IXa (FIXa) and factor X (FX), and enhance the FIXa-catalysed activation of FX to FXa. Use of the bispecific antigen binding molecules to control bleeding, by replacing natural cofactor FVIIIa which is deficient in patients with haemophilia A.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
E-Chiang Lee0
John Kenneth Blackwood0
Roberto Magliozzi0
Wei Wang0
Date of Patent
May 7, 2024
0Patent Application Number
170639050
Date Filed
October 6, 2020
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11976135 FIXaxFX bispecific antibody with common light chain
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
